In contrast, JAK2 deficiency in the liver, macrophages, or adipocytes protects against high-fat diet induced metabolic inflammation [[12], [13], [14]], suggesting that JAK2 may be a promising target for the treatment of obesity, metabolic syndrome and T2DM. The gene discussed is JAK2; the disease is obesity due to melanocortin 4 receptor deficiency.